Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider (CSP) Program. The partnership broadens access to high-quality, scalable single cell sequencing across Australia, the wider Asia-Pacific region, and beyond.

"We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Institute.

Garvan is one of Australia's preeminent medical research institutions, with the Genomics Platform having deep experience in cell sorting, capture, and sequencing. As a Certified Service Provider, Garvan will offer Parse's Evercode WT kits to researchers across the region. "We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Institute.

"Garvan is one of the most respected biomedical research institutions in the world, and we're honored to welcome them to our Certified Service Provider network," said Charlie Roco, Co-founder and CTO of Parse Biosciences. "Our CSP program connects researchers with trusted partners, freeing them to apply their resources elsewhere as needed. Garvan is an ideal partner for this, and we're excited to support more single cell projects across Asia-Pacific together."